COMBINATION THERAPIES FOR TREATMENT OF CANCER

Provided herein are methods of treating cancer in a human subject, comprising administering to the subject: i) an antibody-drug conjugate (ADC) comprising an antibody, a cleavable linker and a cytotoxic agent, and ii) a bispecific checkpoint inhibitor. Further provided herein are kits comprising i)...

Full description

Saved in:
Bibliographic Details
Main Authors ANDERTON, Judith, KINNEER, Krista, ZERON-MEDINA CUAIRAN, Jorge, LUHESHI, Nadia, PALMER, Doug, ACHOUR, Ikbel, OMAR, Bilal, HAMMOND, Scott A, FREEMAN, Daniel J
Format Patent
LanguageEnglish
French
Published 01.02.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Provided herein are methods of treating cancer in a human subject, comprising administering to the subject: i) an antibody-drug conjugate (ADC) comprising an antibody, a cleavable linker and a cytotoxic agent, and ii) a bispecific checkpoint inhibitor. Further provided herein are kits comprising i) an antibody-drug conjugate (ADC) comprising an antibody, a cleavable linker and a cytotoxic agent, and ii) a bispecific checkpoint inhibitor. L'invention concerne des méthodes de traitement du cancer chez un sujet humain, comprenant l'administration au sujet : i) d'un conjugué anticorps-médicament (ADC) comprenant un anticorps, un lieur clivable et un agent cytotoxique, et ii) d'un inhibiteur de point de contrôle bispécifique. L'invention concerne en outre des kits comprenant i) un conjugué anticorps-médicament (ADC) comprenant un anticorps, un lieur clivable et un agent cytotoxique, et ii) un inhibiteur de point de contrôle bispécifique.
Bibliography:Application Number: WO2023IB57657